Posted on Leave a comment

Wearable technology named top health and fitness trend for 2020

health and fitness trend for 2020

More Americans are using wearable fitness trackers than ever to monitor their health, a trend the American College of Sports Medicine says is the top fitness trend for 2020, according to a recent survey.

ACSM’s “Worldwide Survey of Fitness Trends for 2020” interviewed over 3,000 health and fitness professionals, all of which said that wearable technology will be the top trend in fitness next year, with millions of Americans already using such technology to monitor their exercises, heart rate, calorie consumption, sleep quality and step count.

“Wearable tech has become ingrained in today’s culture, and the industry shows no signs of slowing down,” said Walter R. Thompson, Ph.D., ACSM Past President and lead author of the survey and associate dean in the College of Education and Human Development at Georgia State University in Atlanta. “Tech advances have made it easier than ever for users to collect important health metrics and work with fitness professionals and health care providers to improve exercise efficiency, develop healthy lifestyles, manage chronic diseases and, ultimately, increase quality of life.”

This year, ACSM published a new article alongside the survey, “Regional Comparisons: The Worldwide Survey of Fitness Trends,” which compared the top 20 fitness and health-related trends in North America, South America, Europe and China in an effort to gain a better understanding of global developments throughout different regions worldwide. The same methodology was used by ACSM’s “Worldwide Survey of Fitness Trends” in tracking these global trends.

“Through the regional comparison we hope to enhance the scope, reach and relevance of the ACSM fitness trends survey to truly make it an international collaboration,” said Vanessa M. Kercher, Ph.D., M.Ed., co-author of the regional comparison article and a clinical assistant professor in the school of public health at Indiana University. “We plan to continue developing our international partnerships with the goal of improving and expanding the implementation and methodology of the ACSM fitness trends survey. By doing so, we aim to identify fitness trends specific to different international regions so we can explore and communicate regional similarities and differences to readers.”

Wearable fitness devices are expected to evolve quite a bit in the coming years, with Apple patenting  “smart clothes” technology last year that can measure heart rate, blood sugar levels, blood pressure, electrocardiograms, blood oxygen levels and respiration rates all through sensors woven into clothing fabric.

HOW D’OXYVA CAN HELP?

Is your wearable really fitness technology or just more of a fad? If your wearable records heart rate, blood pressure, blood sugar, blood flow (perfusion index), blood oxygen (SpO2), blood pH, we challenge you to prove that you have the best wearable by testing its efficiency with D’OXYVA.

D’OXYVA is the only fully noninvasive, completely painless transdermal (over-the-skin) microcirculatory solution that has been clinically tested to significantly improve microcirculation.

Results of improved blood flow (perfusion index) is visible in just after 5 minutes of D’OXYVA therapy and on its highest just after 30 minutes!

Are you up for the challenge? Register below to get further details! Amazing prizes await!

Posted on Leave a comment

Science underlying D’OXYVA receives the Nobel Prize in Physiology for Medicine in 2019

The Nobel Assembly at Karolinska Institutet has today decided to award the 2019 Nobel Prize in Physiology for Medicine jointly to William G. Kaelin Jr., Sir Peter J. Ratcliffe and Gregg L. Semenza for their discoveries of how cells sense and adapt to oxygen availability.

SUMMARY


Animals need oxygen for the conversion of food into useful energy. The fundamental importance of oxygen has been understood for centuries, but how cells adapt to changes in levels of oxygen has long been unknown.

William G. Kaelin Jr., Sir Peter J. Ratcliffe and Gregg L. Semenza discovered how cells can sense and adapt to changing oxygen availability. They identified molecular machinery that regulates the activity of genes in response to varying levels of oxygen.

The seminal discoveries by this year’s Nobel Laureates revealed the mechanism for one of life’s most essential adaptive processes. They established the basis for our understanding of how oxygen levels affect cellular metabolism and physiological function. Their discoveries have also paved the way for promising new strategies to fight anemia, cancer and many other diseases.

Oxygen at center stage


Oxygen, with the formula O2, makes up about one fifth of Earth’s atmosphere. Oxygen is essential for animal life: it is used by the mitochondria present in virtually all animal cells in order to convert food into useful energy. Otto Warburg, the recipient of the 1931 Nobel Prize in Physiology or Medicine, revealed that this conversion is an enzymatic process.

During evolution, mechanisms developed to ensure a sufficient supply of oxygen to tissues and cells. The carotid body, adjacent to large blood vessels on both sides of the neck, contains specialized cells that sense the blood’s oxygen levels. The 1938 Nobel Prize in Physiology or Medicine to Corneille Heymans awarded discoveries showing how blood oxygen sensing via the carotid body controls our respiratory rate by communicating directly with the brain.

 

HIF enters the scene


In addition to the carotid body-controlled rapid adaptation to low oxygen levels (hypoxia), there are other fundamental physiological adaptations. A key physiological response to hypoxia is the rise in levels of the hormone erythropoietin (EPO), which leads to increased production of red blood cells (erythropoiesis). The importance of hormonal control of erythropoiesis was already known at the beginning of the 20th century, but how this process was itself controlled by O2 remained a mystery.

Gregg Semenza studied the EPO gene and how it is regulated by varying oxygen levels. By using gene-modified mice, specific DNA segments located next to the EPO gene were shown to mediate the response to hypoxia. Sir Peter Ratcliffe also studied O2-dependent regulation of the EPO gene, and both research groups found that the oxygen sensing mechanism was present in virtually all tissues, not only in the kidney cells where EPO is normally produced. These were important findings showing that the mechanism was general and functional in many different cell types.

Semenza wished to identify the cellular components mediating this response. In cultured liver cells he discovered a protein complex that binds to the identified DNA segment in an oxygen-dependent manner. He called this complex the hypoxia-inducible factor (HIF) . Extensive efforts to purify the HIF complex began, and in 1995, Semenza was able to publish some of his key findings, including identification of the genes encoding HIF. HIF was found to consist of two different DNA-binding proteins, so called transcription factors, now named HIF-1α and ARNT. Now the researchers could begin solving the puzzle, allowing them to understand which additional components were involved and how the machinery works.

Figure 1. When oxygen levels are low (hypoxia), HIF-1α is protected from degradation and accumulates in the nucleus, where it associates with ARNT and binds to specific DNA sequences (HRE) in hypoxia-regulated genes (1). At normal oxygen levels, HIF-1α is rapidly degraded by the proteasome (2). Oxygen regulates the degradation process by the addition of hydroxyl groups (OH) to HIF-1α (3). The VHL protein can then recognize and form a complex with HIF-1α leading to its degradation in an oxygen-dependent manner (4).

​VHL: an unexpected partner


When oxygen levels are high, cells contain very little HIF-1α. However, when oxygen levels are low, the amount of HIF-1α increases so that it can bind to and thus regulate the EPO gene as well as other genes with HIF-binding DNA segments (Figure 1). Several research groups showed that HIF-1α, which is normally rapidly degraded, is protected from degradation in hypoxia. At normal oxygen levels, a cellular machine called the proteasome, recognized by the 2004 Nobel Prize in Chemistry to Aaron Ciechanover, Avram Hershko and Irwin Rose, degrades HIF-1α. Under such conditions a small peptide, ubiquitin, is added to the HIF-1α protein. Ubiquitin functions as a tag for proteins destined for degradation in the proteasome. How ubiquitin binds to HIF-1α in an oxygen-dependent manner remained a central question.

The answer came from an unexpected direction. At about the same time as Semenza and Ratcliffe were exploring the regulation of the EPO gene, cancer researcher William Kaelin, Jr. was researching an inherited syndrome, von Hippel-Lindau’s disease (VHL disease). This genetic disease leads to dramatically increased risk of certain cancers in families with inherited VHL mutations. Kaelin showed that the VHL gene encodes a protein that prevents the onset of cancer. Kaelin also showed that cancer cells lacking a functional VHL gene express abnormally high levels of hypoxia-regulated genes; but that when the VHL gene was reintroduced into cancer cells, normal levels were restored. This was an important clue showing that VHL was somehow involved in controlling responses to hypoxia. Additional clues came from several research groups showing that VHL is part of a complex that labels proteins with ubiquitin, marking them for degradation in the proteasome. Ratcliffe and his research group then made a key discovery: demonstrating that VHL can physically interact with HIF-1α and is required for its degradation at normal oxygen levels. This conclusively linked VHL to HIF-1α.

Oxygen sHIFts the balance


Many pieces had fallen into place, but what was still lacking was an understanding of how O2 levels regulate the interaction between VHL and HIF-1α. The search focused on a specific portion of the HIF-1α protein known to be important for VHL-dependent degradation, and both Kaelin and Ratcliffe suspected that the key to O2-sensing resided somewhere in this protein domain. In 2001, in two simultaneously published articles they showed that under normal oxygen levels, hydroxyl groups are added at two specific positions in HIF-1α (Figure 1). This protein modification, called prolyl hydroxylation, allows VHL to recognize and bind to HIF-1α and thus explained how normal oxygen levels control rapid HIF-1α degradation with the help of oxygen-sensitive enzymes (so-called prolyl hydroxylases). Further research by Ratcliffe and others identified the responsible prolyl hydroxylases. It was also shown that the gene activating function of HIF-1α was regulated by oxygen-dependent hydroxylation. The Nobel Laureates had now elucidated the oxygen sensing mechanism and had shown how it works.

Figure 2. The awarded mechanism for oxygen sensing has fundamental importance in physiology, for example for our metabolism, immune response and ability to adapt to exercise. Many pathological processes are also affected. Intensive efforts are ongoing to develop new drugs that can either inhibit or activate the oxygen-regulated machinery for treatment of anemia, cancer and other diseases.

Oxygen shapes physiology and pathology

Thanks to the groundbreaking work of these Nobel Laureates, we know much more about how different oxygen levels regulate fundamental physiological processes. Oxygen sensing allows cells to adapt their metabolism to low oxygen levels: for example, in our muscles during intense exercise. Other examples of adaptive processes controlled by oxygen sensing include the generation of new blood vessels and the production of red blood cells. Our immune system and many other physiological functions are also fine-tuned by the O2-sensing machinery. Oxygen sensing has even been shown to be essential during fetal development for controlling normal blood vessel formation and placenta development.

Oxygen sensing is central to a large number of diseases (Figure 2). For example, patients with chronic renal failure often suffer from severe anemia due to decreased EPO expression. EPO is produced by cells in the kidney and is essential for controlling the formation of red blood cells, as explained above. Moreover, the oxygen-regulated machinery has an important role in cancer. In tumors, the oxygen-regulated machinery is utilized to stimulate blood vessel formation and reshape metabolism for effective proliferation of cancer cells. Intense ongoing efforts in academic laboratories and pharmaceutical companies are now focused on developing drugs that can interfere with different disease states by either activating, or blocking, the oxygen-sensing machinery.

HOW D’OXYVA CAN HELP?

D’OXYVA is the only fully noninvasive, completely painless transdermal (over-the-skin) oxygen-balanced microcirculatory solution that has been clinically tested to significantly improve microcirculation.

The improvement of oxygen-balanced microcirculation, i.e., blood flow to the smallest blood vessels, benefits one’s health, immune system and overall sense of well-being in a variety of ways.

Posted on Leave a comment

Trump Ready To Force Transparency In Healthcare Pricing With An Executive Order

The Trump Administration wants to make it easier for patients and employers to comparison shop for healthcare. On transparency, one can’t fault the Administration for not trying.

So far, the measures implemented have mostly been baby steps. But, this is about to change as President Trump is expected to soon release an executive order on healthcare price transparency. If enacted, this executive order would mandate disclosure of prices throughout the healthcare industry, and be enforceable by federal agencies. It would provide patients and employers pricing data that reflect the negotiated rates between insurers, hospitals, and physicians.

In the lead-up to this week’s expected announcement on the executive order, the Trump Administration has been gradually chipping away to uncover the murky world of healthcare pricing. For example, in October 2018, President Trump signed two bills into law, the Know the Lowest Price Act and the Patients’ Right to Know Drug Prices Act. These bills removed pharmacy gag clauses, imposed by pharmacy benefit managers, which had prevented pharmacists from proactively telling consumers if their prescription would cost less if they paid for it out-of-pocket rather than using their insurance plan.

And, this month, the Department of Health and Human Services (HHS) announced that direct-to-consumer (DTC) advertisements of prescription drugs on television will soon be required to include price information.

Nonetheless, the pharmacy gag clause bills and requirement to include list price information in DTC advertisements only incrementally address prescription drug price transparency. A much bigger step would be to overhaul the prescription drug rebate system, as proposed by HHS. However, it’s unclear whether and when that will happen.

Ultimately, drug price transparency alone won’t be sufficient to create conditions conducive to a competitive market. It needs to be coupled with dissemination of information on which medications are the most effective for specific conditions or diseases. There have been a number of efforts in the commercial sector to address this issue; MedSavvy, for example, which is a Cambia Health Solutions company. Regence Blue Cross and Blue Shield offers MedSavvy to its customers. The federal government is also supporting initiatives to improve the Patient-Centered Outcomes Research Institute’s publication of usable information on comparative effectiveness to consumers. But it’s been a very slow process with few tangible results thus far.

The Trump Administration has also focused on disseminating information regarding the quality of physician practices that serve Medicare beneficiaries. The Centers for Medicare and Medicaid Services (CMS) established a website called Physician Compare. However, nearly 80% of physicians aren’t included in the website database. Reporting is voluntary, and so there’s selection bias when it comes to the performance data that do appear. Moreover, the website doesn’t include a comparison of fees for physician services.

Beginning January 1st this year, the federal government is requiring every hospital in the U.S. to post lists of prices of services and technologies online. Such lists are known in the industry as “chargemasters” that comprise of prices of thousands of services and products for which a hospital may bill.

But, CMS acknowledges it is not yet enforcing the hospital pricing rule. Furthermore, implementation of the rules has sparked a debate about whether the price lists are creating more confusion than clarity among patients. Services and products are identified in acronyms, abbreviations, billing codes, and medical terminology that most consumers can’t be expected to understand.

Additionally, the chargemaster lists don’t normally reflect actual transaction charges because hospitals and insurers generally negotiate significantly lower prices. And, hospitals and insurers are resisting public disclosure of negotiated prices. This week’s expected announcement of an executive order may make such resistance a moot point.

Most patients don’t comparison shop for medical care. Some might not be in a position to do so. Others may simply balk. Perhaps this is due in large part to patients not being used to comparison shopping, or to the opaque character of pricing in the healthcare system. As more useful information becomes available, perhaps patients will begin to do more comparison shopping. which in turn will lead to a more competitive market.

HOW D’OXYVA CAN HELP?

D’OXYVA is the only affordable, fully noninvasive, completely painless transdermal (over-the-skin) microcirculatory solution that has been clinically tested to significantly improve microcirculation.

The improvement of microcirculation, i.e., blood flow to the smallest blood vessels, benefits one’s health, immune system and overall sense of well-being in a variety of ways.

Posted on Leave a comment

7 Subtle Signs That Prove You’re Not As Healthy As You Think You Are

When you say healthy, it often brings to mind an image of person that exercises all the time and only eats nutritious food while avoiding junk like candy and fast food. However, it actually demands so much more than that. Truth is, being truly healthy means that one should have a sense of “physical, mental, and social wellbeing, and the resources to live a full life.”

Of course, we don’t always think of it that way. In fact, in most cases, eating heathy and pairing it with consistent exercise is more than enough. However, while being classified as “overweight” or “underweight” is an obvious sign of being unhealthy, there are also other not-so-obvious signs — ones that you may be ignoring. And ones that may mean you’re not as healthy as you believe you are. Below are some of them.

  1. Snoring – You may think it’s just an embarrassing act, but it can also indicate that you’re not that healthy. In fact, snoring is linked to a variety of health conditions, including sleep apnea, heart disease, and even stroke.
  2. Constant skin breakouts – Skin breakouts are also a sign of general unhealthiness, and unfortunately, there’s no single cause. However, thanks to face mapping, we can now easily adjust our lifestyle based on where we get breakouts. Chin acne for example, means we have to eat healthier, while forehead acne means we need better sleep and hygiene.
  3. The white of your eyes aren’t as white – This one is more subtle, but basically, if your eyes are a tad yellowish, it indicates that you may have complications in your bile ducts, gall bladder, liver or pancreas. There’s also red eyes, which come from lack of sleep and exhaustion.
  4. Your nails have an odd color and texture – A yellowish color in your nails is believed to be caused by fluid build-up and inadequate circulation in the body.
  5. Being gassy – Excessive gas can be signs of an irritable bowel syndrome, lactose intolerance, and celiac disease.
  6. Constant exhaustion – This one is obvious, but continuous exhaustion means that you may have iron deficiency, too little exercise, and even dehydration.
  7. Your urine doesn’t have a pale color – The color, smell, and density of urine can reveal what’s going on in our body. And in this case, having urine that has a darker color or has a strong scent means that you should probably get yourself checked by a doctor ASAP.

Reference: https://www.medicaldaily.com/7-subtle-signs-prove-youre-not-healthy-you-think-you-are-432551

HOW D’OXYVA CAN HELP?

D’OXYVA is the only fully noninvasive, completely painless transdermal (over-the-skin) microcirculatory solution that has been clinically tested to significantly improve microcirculation.

The improvement of microcirculation, i.e., blood flow to the smallest blood vessels, benefits one’s health, immune system and overall sense of well-being in a variety of ways.

Posted on Leave a comment

“People are dying”: Diabetics rationing insulin amid rising drug prices

Drug manufacturers were grilled Wednesday about the skyrocketing price of insulin, which has doubled in the last five years and led some patients to ration the life-saving drug. One study finds the underuse of insulin could affect nearly 40 million people with diabetes by 2030.

“Nobody cared or nobody understood that without this next vial of insulin, I wouldn’t live to see another week,” said 28-year-old Kristen Whitney Daniels.

She started rationing her insulin after she was kicked off her parents’ insurance plan two years ago.

“I can’t really explain how isolating and how terrifying it is,” she said.

She’s now a patient at the Yale Diabetes Center, where a recent Journal of American Medical Association study found one in four patients reported “cost-related underuse.” Dr. Kasia Lipska treats patients at the clinic, and was the study’s lead author. She testified on Capitol Hill last week.

  • Woman says her son couldn’t afford his insulin – now he’s dead
  • Eli Lilly rolling out half-price insulin. Diabetics say it’s not enough

“This vial of insulin cost just $21 when it first came on the market in 1996. It now costs $275,” she said.

Some drug makers are already reacting to the outrage. On Wednesday, Sanofi announced it will cut the price of insulin for uninsured patients and those who pay cash to $99 per month. But that doesn’t eliminate advocate concerns.

“People are dying from lack of access to a drug that has been around for almost a century. I think it’s unconscionable,” Lipska said.

Insulin manufacturers told CBS News they’ve taken steps to address prices, including offering free medication to people who quality.

HOW D’OXYVA CAN HELP?

D’OXYVA is the only fully noninvasive, completely painless transdermal (over-the-skin) microcirculatory solution that has been clinically tested to significantly improve microcirculation.

The improvement of microcirculation, i.e., blood flow to the smallest blood vessels, benefits one’s health, immune system and overall sense of well-being in a variety of ways.

Posted on Leave a comment

Patients are transforming from passive recipients of healthcare services to active participants in their own health

This is a preview of a research report from Business Insider Intelligence, Business Insider’s premium research service. To learn more about Business Insider Intelligence, click here. Current subscribers can read the report here.

 

0201

 

The consumerization of healthcare — a fundamental shift in patients’ preferences, behaviors, and demands around healthcare services — is threatening hospitals’ bottom lines. For the first time, patients are transforming from passive recipients of healthcare services to active participants in their own health. They’re flocking to online review sites to choose which doctor to see, skipping hospital visits in favor of a health clinic in their local CVS, and aren’t afraid to ditch providers that don’t offer them an engaging experience.

The superior customer service expectations of millennials, declines in hospital profitability, and threats from startup providers and retail pharmacies intensify the need for providers to revamp the patient experience. Providers’ current engagement capabilities are weak, and deficiencies around scheduling, appointment wait times, and billing are dragging on patient satisfaction, driving patients elsewhere and draining provider revenue.

In The Healthcare Consumerization ReportBusiness Insider Intelligence explores the trends that are driving providers to revamp their care services. We then outline how patients’ expectations for transparency, convenience, and access are transforming the way they interact with providers across each stage of care. Finally, we detail strategies health systems and hospitals can implement to create a consumer-centric patient experience that fosters satisfaction, loyalty, and patient volume.

The companies mentioned in this report are: 98point6, BayCare, Cleveland Clinic, CVS, Integris, Kaiser Permanente, Luma Health, New York-Presbyterian, One Medical, Publix, Target, Walgreens, Walmart, Yelp, and Zocdoc.

Here are some of the key takeaways from the report:

 

  • The consumerization of healthcare is redefining how consumers engage with providers across each stage of care.
  • But the vast majority of healthcare providers haven’t sufficiently altered their services to align with current patient expectations. Only 8% of US hospitals and health systems demonstrate strong consumer-centric performance, per a 2018 Kaufman Hall survey.
  • Failure to react to patient preferences hurts provider organizations’ bottom lines. US hospital profit margins are already thinning, and an emerging reimbursement model that ties a portion of providers’ compensation to patient satisfaction means providers can’t afford to preserve the status quo.
  • Alternative players with consumer-focused healthcare services threaten to poach patients from traditional health systems. Tech-focused primary care startups, like One Medical and 98point6, and retail outlets, like Target, Walmart, and CVS, offer patients on-demand access to healthcare providers via mobile apps and convenient locations to receive healthcare services, drawing them away from incumbent health systems.
  • In order to retain patients — and keep them from straying to alternative care services — providers must transform their services with an emphasis on transparency, access, and ongoing engagement outside of the clinic.
  • Healthcare providers that tailor their services to the new healthcare consumer will be well positioned to see growth. Alternatively, businesses that don’t implement these changes could find themselves falling behind the rest of the industry or closing their doors for good.

 

In full, the report:

  • Details how patient behavior, preferences, and expectations have changed.
  • Outlines the demographic and industry trends that should add a sense of urgency for providers to revamp the patient experience.
  • Summarizes how the patient experience providers currently offer isn’t conducive to loyalty and is likely driving patients to nonhospital services.
  • Explains strategies health systems and hospitals can implement to create a consumer-centric patient experience that fosters satisfaction, loyalty, and patient volume.
  • Offers examples of provider organizations that have successfully adopted new strategies to encourage patient-doctor communication, improve satisfaction, and drive scheduling capacity.

 

Reference: https://www.businessinsider.com/the-healthcare-consumerization-report-2018-11?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed:+businessinsider+%28Business+Insider%29

Posted on Leave a comment

Apple Watch 4 can detect D’OXYVA’s benefits.

Did you recently buy yourself a Christmas gift?

Would it happen to be the new Apple Watch Series 4? If so, did you know you can use it to detect D’OXYVA’s benefits?

D’OXYVA is the only fully non-invasive, completely painless, transdermal (over-the-skin) microcirculatory solution that has been clinically tested to significantly improve microcirculation.

The improvement of microcirculation, i.e., blood flow to the smallest blood vessels, benefits your health, your immune system and your overall sense of well-being in a variety of ways.

D’OXYVA® plays a vital role in regulating and creating homeostasis (stability) in the autonomic nervous system (ANS) or, more precisely, between its main two functions, the sympathetic and parasympathetic nerve activities.

D’OXYVA® has been shown to achieve this by stimulating parasympathetic nerve activities that are responsible for “rest and digest” functions, reducing heart rate, blood pressure, calming, regenerating, healing, and energy reservation.

About Apple Watch 4

One of the biggest upgrades to the Apple Watch Series 4 from its predecessor is its ability to record an electrocardiogram and detect issues with how the user’s heart is functioning. The company’s FDA-approved feature is now live for users in the US.

The device can detect irregularities in your heartbeat, which can point to critical conditions like atrial fibrillation that may result in a stroke. If your Watch classifies your rhythm as a high heart rate or atrial fibrillation, you’ll want to talk to your doctor.

However, it’s worth noting that the Watch only records a basic single-lead ECG, so it can’t detect a stroke, heart attack, or other heart conditions like the 12-lead ECGs taken at a doctor’s office.

If you’re using a Watch Series 4 in the US, here’s how you can take an ECG:

• Ensure your device is updated to watch OS 5.1.2 and paired with an iPhone 5s or later with iOS 12.1.1 on board.

• Set up the ECG app by opening Apple Health on your device and following the on-screen instructions. A prompt should show up automatically, but if you don’t see it, head to Health Data > Heart > Electrocardiogram (ECG).

• Wear your Watch 4 with a snug fit on the wrist you’ve specified in the Apple Watch app (you can find or change this in the Apple Watch app; tap the My Watch tab, then head to General > Watch Orientation).

• Launch the ECG app on your Watch.

• Rest your arms comfortably on a table or in your lap.

• Hold your finger on the Digital Crown without pressing down for 30 seconds. You’ll then see your results and any symptoms that the device detects.
Tap Save to record your symptoms.

• To review your ECG, open the Health app on your iPhone and head to the Health Data tab. Then, tap Heart > Electrocardiogram (ECG), and tap the ECG. You’ll find an option to export a PDF of it, which you can share with your doctor.

 

References:
https://www.msn.com/en-us/news/technology/apple-wa…
https://www.doxyva.com/kb_results.asp?ID=64

Posted on Leave a comment

Did you know when used in a regimen, D`OXYVA users have reported a number of health and beauty benefits?

doxyva benefits

OPTIMIZE BLOOD CIRCULATION FOR A WIDE VARIETY OF SIGNIFICANT OUTCOMES

D’OXYVA® (deoxyhemoglobin vasodilator) in various clinical trials has validated leading independent research results and demonstrated above-average results in improving a host of physiological functions at the same time.

People using D’OXYVA® have recorded significant improvements in cardiovascular activity leading to much improved physical activity. As part of a healthy lifestyle, D’OXYVA may help significantly reduce the risk of high blood pressure, hypertension, cholesterol, and diabetes in just two or three months, with an average use of 5 minutes a day and 5 times a week.

Poor circulation is a gateway for a litany of ailments: slow healing, depression, poor complexion, sores, slow metabolism, and more.

D’OXYVA significantly improves sustained oxygen-rich microcirculatory blood flow locally and throughout the body. Its patented method of fully non-invasive, painless, and harmless transdermal delivery is unique only to D’OXYVA.

When used daily, D’OXYVA users have reported a number of health and beauty benefits, including but not limited to:

  • Relief from symptoms of microvascular complications
  • Significantly increased cardiac function, physical fitness, endurance and strength, muscle size, body tone, faster recovery from sports injuries and surgical trauma
  • Improved self-esteem via promoting healthy and radiant skin, complexion, dry skin relief, and acne reduction
  • Significant reduction in downtime from other skin treatments and cosmetic procedures when used in combination, reduction in the appearance of scars, cellulite, fat, spider veins and stretch marks
  • Promoting and maintaining a healthy weight, improving general mobility, deeper, more restful sleep
  • Significant improvement of mental acuity; concentration, problem solving, multitasking, eye-hand coordination, heightened stamina, energy, and focus while managing stress
  • Improved vitals across the board during checkups with zero adverse event reports after years of regular use by people with various health, demographic, and ethnic backgrounds

HOW D’OXYVA CAN HELP?

D’OXYVA is the only fully noninvasive, completely painless transdermal (over-the-skin) microcirculatory solution that has been clinically tested to significantly improve microcirculation.

The improvement of microcirculation, i.e., blood flow to the smallest blood vessels, benefits one’s health, immune system and overall sense of well-being in a variety of ways.

Posted on Leave a comment

8 Warning Signs of Poor Blood Circulation

Poor blood circulation is the start of numerous other ailments.

What causes poor blood circulation?

Low blood circulation is caused by different underlying conditions. The most common ones are atherosclerosis (“hardening of the arteries) and peripheral artery disease (PAD).

If you experience symptoms of blood circulation problems, consult your physician right away. Poor circulation can lead to heart attack, stroke and even death.

What are the signs of poor blood circulation?

Symptoms of poor blood circulation mostly occur in the hands, feet, arms, and legs. Here are 8 signs to look out for…

  1. Leg Pain While Walking

A common symptom of poor blood circulation is pain or cramping of your leg or hip muscles. This is felt while walking, climbing stairs or another similar physical activity. This is a condition called intermittent claudication, which is a sign of PAD.

  1. Numbness and Weakness

Your arms or legs may feel weak or numb. This can happen while you are moving, or even sitting still.

If these symptoms in your arms and legs come about suddenly and are accompanied by impaired or slurred speech and drooping facial muscles, you may have low blood circulation to your brain due to atherosclerosis.

Poor circulation in the arteries which supply blood to the brain can cause a stroke.

  1. Coldness and Swelling

If your feet, hands or lower legs feel cold all the time for no apparent reason – it is a sign of poor blood circulation.

Low blood circulation due to PAD or atherosclerosis tends to produce coldness in one foot, hand or leg more than the other. You could also notice swelling in your extremities due to poor circulation, particularly in your legs and feet.

  1. Non-healing Sores

Sores on your feet or legs that don’t seem to heal are a common sign. You may also notice that ulcers or infections in your legs and feet heal very slowly.

You may also notice that you’re losing hair on your legs and feet or that your hair is growing slower than normal. Your toenails may grow slowly as well.

  1. Changes in Skin Colour

Poor circulation can cause your skin in your arms, hands, legs and feet to change colour. You may notice that your skin looks “shiny”.

Your legs and feet may turn pale or bluish in colour, due to the poor blood and oxygen delivery to your extremities.

  1. Weak Pulse in Your Legs

Poor blood circulation due to atherosclerosis or PAD can cause your pulse to become weak in your feet or legs.

When the pulse in your limbs is weak or absent, this means that there is little or no blood circulation to these areas.

The most common method that doctors use to determine blood flow problems is to check your pulse in the leg and groin areas.

  1. Chest Pain

Chest pain or angina, and other symptoms of a heart attack are signs of poor blood circulation in the arteries to your heart.

This may be a sign of atherosclerosis in these arteries. If you have chest pain, you should see your doctor right away to prevent a potentially life-threatening medical problem.

  1. Erectile Dysfunction

If you’re a man, experiencing erectile dysfunction can be a sign of low blood circulation.

Erectile problems can indicate poor blood flow to your groin and lower extremities due to one or more blocked, clogged, or narrowed arteries.

D’OXYVA (deoxyhemoglobin vasodilator) delivers the highest possible concentration of CO2 and has been clinically studied to SIGNIFICANTLY INCREASE BLOOD FLOW volume in the microcirculatory system.

In short, based on current leading neurology, immunology, microvascular, and cellular oxygenation science, D’OXYVA is leading the field by quickly targeting to:

Significantly lower the risk of diabetes and cardiovascular complications

Provide complete healing of difficult wounds together with major pain relief and improved quality of life:

  • Detoxify the skin and body
  • Improve sleep
  • Stamina and skin health
  • Reduce inflammation
  • And much more for all kinds of people
Posted on Leave a comment

CARBON DIOXIDE AND HUMAN HEALTH

Pollutants are dangerous compounds for living beings.

Like water, CO2 is vital for life on Earth; thus, CO2 is not a pollutant or contaminant.

The specific heat of CO2 is 850 J/Kg K, which means carbon dioxide is able to absorb, store and emit heat. However, we cannot take this property into account when considering if CO2 is a pollutant because Water has a specific heat of 1,996 J/kg K, which means it is more efficient than CO2 at absorbing, emitting and storing heat. Water, like CO2, is vital for living beings.

CO2 densities have increased to more than 4000 ppmv in some geological eras, for example, during the Ordovician Period (Scotesse; 2002. Avildsen et al1998). When CO2 in the terrestrial atmosphere has reached densities this high in the past, life flourished abundantly. Consequently, we cannot consider such a high concentration of atmospheric CO2 as “pollution”.

CO2 is the basic nutrient for plants and other photosynthetic organisms. Plants form the base of every food chain. Thus, the greater the density of CO2 in a given environment, the greater will be the production of food for plants and of the animals that feed on them.

In recent times it has become fashionable to relate CO2 to global warming, but water in its liquid or gaseous phase absorbs, stores and emits heat 4 times (400%) more efficiently than CO2. If, therefore, by this property water is not considered a pollutant, CO2 then cannot be considered a pollutant either.

Carbon Dioxide cannot intoxicate because it is a non-poisonous non-toxic substance. The data for CO2 related to human health are next:

  • The density of CO2 in the atmosphere is 0.000747 Kg per cubic meter of air.

Normal CO2 Levels. The effects of an increased level of CO2 on an adult person in good health can be summarized as:

  • Normal outside levels: 350 – 600 ppmv.
  • Acceptable levels: up to 600 ppmv.
  • Stiffness and odors: 600 – 1000 ppmv.

Data provided by the Occupational Safety and Health Administration (OSHA):

  • Standards: 1000 ppmv.
  • Stupor: 1000 – 2500 ppm.
  • Maximum allowed concentration in an 8 hour working period: 5,000 ppmv.

Extreme and Dangerous CO2 Levels:

  • Nausea and increase of the cardiac and respiratory frequencies (from oxygen deficiency): 30,000 ppmv.
  • The above plus headaches and sight impairment: 50,000 ppmv.
  • Unconsciousness and death: 100,000 ppmv (OSHA).

As you can see, Carbon Dioxide does not intoxicate — it suffocates. All of the effects listed above correspond to asphyxia, not to poisoning; however, water and sand also asphyxiate and they are not considered pollutants either. Consequently, CO2 cannot be considered a pollutant merely because it asphyxiates.

Many have tried to tag CO2 as a pollutant simply because it is a product of fossil fuel combustion. However, CO2 is also a product of respiration, fermentation and putrefaction. In any case, the CO2 released by combustion of fossil fuels had previously been taken from the atmosphere by photosynthetic organisms and converted into organic compounds to be used in their metabolic functions as structures for reproduction, etc. When those photosynthetic organisms later died, their remains were subjected to strong geological processes that convert organic matter into oil, coal and methane. (Reccommended reading: The Holocene CO2 Rise: Anthropogenic or Natural?)

Those products are the fossil fuels that we use today to power our industries and vehicles; therefore, we are only returning CO2 to the place it once occupied during the Carboniferous Period. CO2 cannot then be considered a pollutant just because it is released back into the atmosphere by combustion of organic fuels and from many other natural processes unrelated with life.

HOW D’OXYVA CAN HELP?

D’OXYVA is the only fully noninvasive, completely painless transdermal (over-the-skin) microcirculatory solution that has been clinically tested to significantly improve microcirculation.

The improvement of microcirculation, i.e., blood flow to the smallest blood vessels, benefits one’s health, immune system and overall sense of well-being in a variety of ways.